Richard J Heads Selected Research

Transcription Factor Brn-3B

1/2019	The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.
4/2005	Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard J Heads Research Topics

Disease

3	Hypertrophy 01/2017 - 09/2006
3	Infarction (Infarctions) 09/2009 - 08/2003
3	Ischemia 09/2006 - 08/2003
2	Hypertension (High Blood Pressure) 01/2021 - 05/2014
2	Breast Neoplasms (Breast Cancer) 01/2011 - 04/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2009 - 08/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Infections 01/2021
1	Inflammation (Inflammations) 01/2021
1	COVID-19 01/2021
1	Body Weight (Weight, Body) 01/2019
1	Reperfusion Injury 01/2018
1	Fibrosis (Cirrhosis) 02/2014
1	Neoplasms (Cancer) 01/2011
1	Hypoxia (Hypoxemia) 09/2007
1	Myocardial Infarction 06/2007
1	Heart Failure 01/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2005
2	CytokinesIBA 01/2021 - 01/2006
2	Toll-Like Receptor 4IBA 01/2021 - 02/2014
2	Transcription Factor Brn-3BIBA 01/2019 - 04/2005
2	Angiotensin IIIBA 01/2019 - 05/2014
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 02/2014
2	CollagenIBA 05/2014 - 02/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2014 - 01/2006
2	CalcineurinIBA 02/2014 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 02/2014 - 01/2006
2	SB 203580IBA 09/2009 - 08/2003
2	Small Heat-Shock ProteinsIBA 09/2009 - 04/2005
1	Estrogens (Estrogen)FDA Link 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2019
1	phospholambanIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2017
1	Oxidants (Oxidizing Agents)IBA 05/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2014
1	Calcitonin Gene-Related PeptideIBA 05/2014
1	AntioxidantsIBA 05/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2014
1	Lipocalin-2IBA 02/2014
1	Fibronectins (Fibronectin)IBA 02/2014
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2014
1	Protein Kinase C-epsilonIBA 02/2014
1	Connective Tissue Growth FactorIBA 02/2014
1	Complementary DNA (cDNA)IBA 01/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2011
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	Nerve Growth Factor (NGF)IBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	MAP-kinase-activated kinase 2IBA 09/2009
1	Oxygen (Dioxygen)IBA 09/2007
1	MAP Kinase Kinase 3IBA 06/2007
1	Protein Isoforms (Isoforms)IBA 09/2006
1	CalciumIBA 01/2006
1	POU Domain FactorsIBA 04/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2003
1	p38 Mitogen-Activated Protein KinasesIBA 08/2003
1	Pharmaceutical PreparationsIBA 08/2003